Epstein-Barr Virus Shed in Saliva Is High in B-Cell-Tropic Glycoprotein gp42
- 15 July 2006
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (14) , 7281-7283
- https://doi.org/10.1128/jvi.00497-06
Abstract
Epstein-Barr virus is an orally transmitted human herpesvirus that infects epithelial cells and establishes latency in memory B lymphocytes. Movement of virus between the two cell types is facilitated by changes in amounts of an envelope glycoprotein, gp42, which are effected by interaction of gp42 with HLA class II in a B cell. Here we used the differential ability of virus to bind to CD21-positive B cells and CD21-negative epithelial cells, which is also influenced by levels of gp42, to determine that the majority of virus shed in saliva is derived from an HLA class II-negative cell.Keywords
This publication has 32 references indexed in Scilit:
- Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In VivoJournal of Virology, 2005
- Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic CarriersJournal of Virology, 2004
- Use of gHgL for Attachment of Epstein-Barr Virus to Epithelial Cells Compromises InfectionJournal of Virology, 2004
- Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cellsNature Medicine, 2003
- Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virusNature Medicine, 2002
- A Defective, Rearranged Epstein-Barr Virus Genome in EBER-Negative and EBER-Positive Hodgkin's DiseaseThe American Journal of Pathology, 2002
- Epstein–Barr Virus Lacking Glycoprotein gp85 Cannot Infect B Cells and Epithelial CellsVirology, 2000
- Coreceptor restriction within the HLA-DQ locus for Epstein–Barr virus infectionProceedings of the National Academy of Sciences, 2000
- Salivary and serum IgA antibodies to the epstein—barr virus glycoprotein gp340: incidence and potential for virus neutralizationInternational Journal of Cancer, 1991
- Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosisCell, 1987